Good morning :)
Molbio Diagnostics Limited

Molbio Diagnostics Limited

MOLBIO Share Price

NSE
₹1,259.704.76% (-62.90)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
SIP

With a market cap of ₹18,143 cr, stock is ranked 397

Stock is 6.84x as volatile as Nifty

MOLBIO Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹18,143 cr, stock is ranked 397

Stock is 6.84x as volatile as Nifty

MOLBIO Performance & Key Metrics

MOLBIO Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
—13.86—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
44.185.540.51%

MOLBIO Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 3 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

MOLBIO Company Profile

Molbio Diagnostics Limited develops and manufactures chip-based diagnostic devices, reagents, and digital pathology solutions including Truenat PCR platform and ultraportable AI-powered X-Ray systems for infectious and non-infectious disease diagnostics.

MOLBIO Similar Stocks (Peers)

Compare with peers Compare with peers 

MOLBIO Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
40.25
40.25
1Y Return
7.95%
7.95%
Buy Reco %
77.78
77.78
PE Ratio
50.15
50.15
1Y Return
24.66%
24.66%
Buy Reco %
80.00
80.00
PE Ratio
64.32
64.32
1Y Return
76.62%
76.62%
Buy Reco %
0.00
0.00
PE Ratio
123.14
123.14
1Y Return
6.41%
6.41%
Buy Reco %
100.00
100.00
PE Ratio
16.73
16.73
1Y Return
4.36%
4.36%
Buy Reco %
0.00
0.00
Compare with Peers

MOLBIO Forecast

MOLBIO Forecasts

Price

Revenue

Earnings

MOLBIO

MOLBIO

Income

Balance Sheet

Cash Flow

MOLBIO Income Statement

MOLBIO Income Statement

Loading...

Quarterjun 2025mar 2026jun 2026
Total Revenue100.47565.41411.48
Operating & Other expensessubtract115.81401.90307.79
Depreciation/Amortizationsubtract12.3219.6017.08
Interest & Other Itemssubtract3.6112.0810.70
Taxes & Other Itemssubtract-7.5641.0117.17
EPS-2.108.055.21

MOLBIO Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
 

MOLBIO Stock Peers

MOLBIO Past Performance & Peer Comparison

MOLBIO Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHealth Care Equipment & Supplies

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Molbio Diagnostics Limited108.9013.86—
Inventurus Knowledge Solutions Ltd40.2510.37—
Poly Medicure Limited50.155.130.22%
Fischer Medical Ventures Ltd64.325.380.02%
ScreenerCompare valuation on Screener

MOLBIO Stock Price Comparison

Compare MOLBIO with any stock or ETF
Compare MOLBIO with any stock or ETF
MOLBIO
Loading...

MOLBIO Holdings

MOLBIO Shareholdings

MOLBIO Promoter Holdings Trend

MOLBIO Promoter Holdings Trend

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

MOLBIO Institutional Holdings Trend

MOLBIO Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

MOLBIO Shareholding Pattern

MOLBIO Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding41.29%8.03%11.06%1.59%38.03%

Aug 2025

Aug 2026

Sep 2026

MOLBIO Shareholding History

MOLBIO Shareholding History

AugAugSep0.00%1.51%1.59%

Mutual Funds Invested in MOLBIO

Mutual Funds Invested in MOLBIO

No mutual funds holding trends are available

Top 5 Mutual Funds holding Molbio Diagnostics Limited




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
1.9839%0.54%0.54%75/78 (+2)
1.6593%0.28%0.28%79/89 (+10)
1.0821%2.17%2.17%114/141 (+18)

Compare 3-month MF holding change on Screener

MOLBIO Insider Trades & Bulk Stock Deals

MOLBIO Insider Trades & Bulk Stock Deals

Loading...

smallcases containing MOLBIO stock

smallcases containing MOLBIO stock

Looks like this stock is not in any smallcase yet.

MOLBIO Events

MOLBIO Events

MOLBIO Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

MOLBIO has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

MOLBIO Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

MOLBIO has not given any dividends in last 5 years

MOLBIO Dividends

MOLBIO Dividends

Hmm, looks like data is unavailable here. Please come back after some time

MOLBIO Stock News & Opinions

MOLBIO Stock News & Opinions

Corporate
Corporate
Molbio Diagnostics confirms electronic shareholding via KFin Technologies for September quarter

Molbio Diagnostics Limited informed the BSE Limited and National Stock Exchange of India Ltd that KFin Technologies Limited, its Registrar and Share Transfer Agent, has issued a certificate for the quarter ended September 30, 2026, as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming that the entire holding of the company was in electronic mode and no rematerialisation requests were received during the period.

2 weeks agoCapital Market - Live
Corporate
Corporate
Molbio Diagnostics closes trading window for insiders ahead of quarterly results

Molbio Diagnostics Limited informed the BSE Limited and National Stock Exchange of India Ltd that the trading window for dealing in the company's securities will be closed for all insiders and designated persons and their immediate relatives from October 01, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended September 30, 2026.

3 weeks agoCapital Market - Live
Corporate
Corporate
Molbio Diagnostics' board re-appointed K. S. Kamalakara & Co as Cost Auditors

Molbio Diagnostics Limited informed the Bombay Stock Exchange and National Stock Exchange of India that its board of directors approved the re-appointment of M/s K. S. Kamalakara & Co, a Peer-reviewed firm with Firm Reg. No: 000296, as the Cost Auditors of the company for the financial year 2026-27.

3 weeks agoCapital Market - Live
Corporate
Corporate
Molbio Diagnostics to review quarterly results at board meeting on September 5, 2026

Molbio Diagnostics Limited will hold a board meeting on September 5, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, as announced in a filing with the BSE Limited and National Stock Exchange of India Ltd. The trading window for the company's shares will remain closed from August 21, 2026, until 48 hours after the approval of the financial results.

1 month agoCapital Market - Live
Corporate
Corporate
Molbio Diagnostics appoints Darshan Karekar as Compliance Officer, per SEBI regulations

Molbio Diagnostics Limited announced that its Board of Directors designated Mr. Darshan Raghunath Karekar as the Compliance Officer of the company under the SEBI (Prohibition of Insider Trading) Regulations, 2015, at a meeting held on August 27, 2026, which commenced at 04.56 P.M. and concluded at 05.08 P.M.

1 month agoCapital Market - Live
Corporate
Corporate
Molbio Diagnostics closes trading window for insiders ahead of financial results

Molbio Diagnostics Limited informed the BSE Limited and National Stock Exchange of India Ltd that the trading window for dealing in the company's securities will be closed for all insiders and designated persons and their immediate relatives from August 21, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026.

2 months agoCapital Market - Live

Frequently asked questions

  1. The share price of MOLBIO as on 22nd October 2026 is ₹1259.70. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of Molbio Diagnostics Limited (MOLBIO) share are
    • Past 1 week: -13.87%
    • Past 1 month: 2.23%
    • Past 3 months: N/A%
    • Past 6 months: 20.93%
    • Past 1 year: 20.93%
    • Past 3 years: N/A%
    • Past 5 years: 20.93%

  3. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Molbio Diagnostics Limited (MOLBIO) is ₹18143.38 Cr as of 22nd October 2026.

  4. The 52-week high of Molbio Diagnostics Limited (MOLBIO) is ₹1686.80 and the 52-week low is ₹926.35.

  5. The P/E (price-to-earnings) ratio of Molbio Diagnostics Limited (MOLBIO) is 108.90. The P/B (price-to-book) ratio is 13.86.

  6. Molbio Diagnostics Limited (MOLBIO) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.

  7. You can directly buy Molbio Diagnostics Limited (MOLBIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.